StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$58.65+0.77 (+1.33%)

Close on Nov 18, 2026Market cap $3.00BP/E 139.6Yield –

Vericel net income

Net income is the profit left for shareholders after every expense, interest and tax.

Vericel's net income for the twelve months ending Jun 30, 2026 was $24.22M, up 240.8% year over year. For fiscal 2025 it was $16.52M, up 59.4% from the year before. The highest annual figure on record is $16.52M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.52M+59.4%
FY2024Dec 31, 2024$10.36M–
FY2023Dec 31, 2023-$3.18M–
FY2022Dec 31, 2022-$16.71M–
FY2021Dec 31, 2021-$7.47M-360.9%
FY2020Dec 31, 2020$2.86M–
FY2019Dec 31, 2019-$9.67M–
FY2018Dec 31, 2018-$8.14M–
FY2017Dec 31, 2017-$17.29M–
FY2016Dec 31, 2016-$19.57M–
FY2015Dec 31, 2015-$16.34M–
FY2014Dec 31, 2014-$19.92M–
FY2013Dec 31, 2013-$15.62M–
FY2012Dec 31, 2012-$29.47M–
FY2010Jun 30, 2010-$14.56M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.21M–
Q1 FY2026Mar 31, 2026-$6.30M–
Q4 FY2025Dec 31, 2025$23.24M+17.3%
Q3 FY2025Sep 30, 2025$5.07M–
Q2 FY2025Jun 30, 2025-$553.00K–
Q1 FY2025Mar 31, 2025-$11.25M–
Q4 FY2024Dec 31, 2024$19.81M+52.4%
Q3 FY2024Sep 30, 2024-$901.00K–
Q2 FY2024Jun 30, 2024-$4.68M–
Q1 FY2024Mar 31, 2024-$3.86M–
Q4 FY2023Dec 31, 2023$12.99M+119.4%
Q3 FY2023Sep 30, 2023-$3.66M–
Q2 FY2023Jun 30, 2023-$5.02M–
Q1 FY2023Mar 31, 2023-$7.50M–
Q4 FY2022Dec 31, 2022$5.92M+30.6%
Q3 FY2022Sep 30, 2022-$6.58M–
Q2 FY2022Jun 30, 2022-$8.96M–
Q1 FY2022Mar 31, 2022-$7.09M–
Q4 FY2021Dec 31, 2021$4.54M-62.9%
Q3 FY2021Sep 30, 2021-$4.93M-236.3%
Q2 FY2021Jun 30, 2021-$3.79M–
Q1 FY2021Mar 31, 2021-$3.29M–
Q4 FY2020Dec 31, 2020$12.22M+28.6%
Q3 FY2020Sep 30, 2020$3.62M+4.3%
Q2 FY2020Jun 30, 2020-$8.27M–
Q1 FY2020Mar 31, 2020-$4.71M–
Q4 FY2019Dec 31, 2019$9.50M+81.2%
Q3 FY2019Sep 30, 2019$3.47M–
Q2 FY2019Jun 30, 2019-$19.79M–
Q1 FY2019Mar 31, 2019-$2.84M–
Q4 FY2018Dec 31, 2018$5.24M+1726.5%
Q3 FY2018Sep 30, 2018-$1.07M–
Q2 FY2018Jun 30, 2018-$4.65M–
Q1 FY2018Mar 31, 2018-$7.66M–
Q4 FY2017Dec 31, 2017$287.00K0.0%
Q3 FY2017Sep 30, 2017-$5.41M–
Q2 FY2017Jun 30, 2017-$2.39M–
Q1 FY2017Mar 31, 2017-$9.78M–
Q4 FY2016Dec 31, 2016$287.00K–
Q3 FY2016Sep 30, 2016-$6.68M–

More Vericel figures

See a number that looks wrong?